Rare lephants
Screener

SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
425 Sep 14, 2017 8-K
425 Sep 11, 2017 425
8-K Sep 11, 2017 8-K
10-Q Aug 14, 2017 10-Q
425 Aug 14, 2017 425
8-K Aug 14, 2017 8-K
NT 10-Q Aug 9, 2017 NT 10-Q
425 Aug 8, 2017 425
8-K Aug 8, 2017 8-K
8-K Aug 8, 2017 8-K
425 Aug 8, 2017 8-K
8-K Jul 28, 2017 8-K
EFFECT Jul 18, 2017
POS AM Jul 12, 2017 POS AM
8-K Jul 11, 2017 8-K
4 Jul 6, 2017 PRIMARY DOCUMENT
4 Jul 6, 2017 PRIMARY DOCUMENT
4 Jul 6, 2017 PRIMARY DOCUMENT
4 Jul 6, 2017 PRIMARY DOCUMENT
4 Jul 6, 2017 PRIMARY DOCUMENT
4 Jul 6, 2017 PRIMARY DOCUMENT
4 Jul 6, 2017 PRIMARY DOCUMENT
8-K Jul 6, 2017 8-K
DEFA14A Jun 29, 2017 DEFINITIVE ADDITIONAL MATERIALS
DEFA14A Jun 26, 2017 DEFINITIVE ADDITIONAL MATERIALS
← Newer Page 21 of 51 · 1272 filings Older →